ArticleCancer research communications2026

Integrated Genetic Screening Identifies FEN1 as a Selective Vulnerability and Temozolomide Resistance Mediator in Glioblastoma Stem Cells.

Benjamin A Brakel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.